180 related articles for article (PubMed ID: 36265795)
1. Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression.
Miller DR; Ingersoll MA; Chou YW; Kosmacek EA; Oberley-Deegan RE; Lin MF
Free Radic Biol Med; 2022 Nov; 193(Pt 1):274-291. PubMed ID: 36265795
[TBL] [Abstract][Full Text] [Related]
2. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance.
Miller DR; Ingersoll MA; Chatterjee A; Baker B; Shrishrimal S; Kosmacek EA; Zhu Y; Cheng PW; Oberley-Deegan RE; Lin MF
Free Radic Biol Med; 2019 Aug; 139():24-34. PubMed ID: 31100478
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.
Veeramani S; Chou YW; Lin FC; Muniyan S; Lin FF; Kumar S; Xie Y; Lele SM; Tu Y; Lin MF
Free Radic Biol Med; 2012 Jul; 53(1):95-108. PubMed ID: 22561705
[TBL] [Abstract][Full Text] [Related]
4. p66Shc regulates migration of castration-resistant prostate cancer cells.
Ingersoll MA; Chou YW; Lin JS; Yuan TC; Miller DR; Xie Y; Tu Y; Oberley-Deegan RE; Batra SK; Lin MF
Cell Signal; 2018 Jun; 46():1-14. PubMed ID: 29462661
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells.
Veeramani S; Yuan TC; Lin FF; Lin MF
Oncogene; 2008 Aug; 27(37):5057-68. PubMed ID: 18504439
[TBL] [Abstract][Full Text] [Related]
6. p66shc-mediated toxicity of high-dose α-tocopherol in renal proximal tubule cells.
Reed DK; Carter A; Dixit M; Arany I
J Physiol Biochem; 2017 May; 73(2):267-273. PubMed ID: 28155123
[TBL] [Abstract][Full Text] [Related]
7. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.
Alaoui-Jamali MA; Bismar TA; Gupta A; Szarek WA; Su J; Song W; Xu Y; Xu B; Liu G; Vlahakis JZ; Roman G; Jiao J; Schipper HM
Cancer Res; 2009 Oct; 69(20):8017-24. PubMed ID: 19808972
[TBL] [Abstract][Full Text] [Related]
8. Pro-oxidant vitamin C mechanistically exploits p66Shc/Rac1 GTPase pathway in inducing cytotoxicity.
Mir HA; Ali R; Wani ZA; Khanday FA
Int J Biol Macromol; 2022 Apr; 205():154-168. PubMed ID: 35181322
[TBL] [Abstract][Full Text] [Related]
9. Protocatechuic Acid-Mediated miR-219a-5p Activation Inhibits the p66shc Oxidant Pathway to Alleviate Alcoholic Liver Injury.
Fu R; Zhou J; Wang R; Sun R; Feng D; Wang Z; Zhao Y; Lv L; Tian X; Yao J
Oxid Med Cell Longev; 2019; 2019():3527809. PubMed ID: 31428222
[TBL] [Abstract][Full Text] [Related]
10. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species.
Zhao Y; Wang Z; Feng D; Zhao H; Lin M; Hu Y; Zhang N; Lv L; Gao Z; Zhai X; Tian X; Yao J
Theranostics; 2019; 9(5):1510-1522. PubMed ID: 30867846
[No Abstract] [Full Text] [Related]
11. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.
Li Y; Su J; DingZhang X; Zhang J; Yoshimoto M; Liu S; Bijian K; Gupta A; Squire JA; Alaoui Jamali MA; Bismar TA
J Pathol; 2011 May; 224(1):90-100. PubMed ID: 21381033
[TBL] [Abstract][Full Text] [Related]
12. Diallyl trisulfide-induced prostate cancer cell death is associated with Akt/PKB dephosphorylation mediated by P-p66shc.
Borkowska A; Sielicka-Dudzin A; Herman-Antosiewicz A; Wozniak M; Fedeli D; Falcioni G; Antosiewicz J
Eur J Nutr; 2012 Oct; 51(7):817-25. PubMed ID: 22020565
[TBL] [Abstract][Full Text] [Related]
13. The pro-oxidant adaptor p66SHC promotes B cell mitophagy by disrupting mitochondrial integrity and recruiting LC3-II.
Onnis A; Cianfanelli V; Cassioli C; Samardzic D; Pelicci PG; Cecconi F; Baldari CT
Autophagy; 2018; 14(12):2117-2138. PubMed ID: 30109811
[TBL] [Abstract][Full Text] [Related]
14. Gambogic Acid Inhibits Malignant Melanoma Cell Proliferation Through Mitochondrial p66shc/ROS-p53/Bax-Mediated Apoptosis.
Liang L; Zhang Z
Cell Physiol Biochem; 2016; 38(4):1618-30. PubMed ID: 27119348
[TBL] [Abstract][Full Text] [Related]
15. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells.
Gueron G; De Siervi A; Ferrando M; Salierno M; De Luca P; Elguero B; Meiss R; Navone N; Vazquez ES
Mol Cancer Res; 2009 Nov; 7(11):1745-55. PubMed ID: 19903769
[TBL] [Abstract][Full Text] [Related]
16. p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.
Rajendran M; Thomes P; Zhang L; Veeramani S; Lin MF
Cancer Metastasis Rev; 2010 Mar; 29(1):207-22. PubMed ID: 20111892
[TBL] [Abstract][Full Text] [Related]
17. The oxidoreductase p66Shc acts as tumor suppressor in BRAFV600E-transformed cells.
Furlan T; Khalid S; Nguyen AV; Günther J; Troppmair J
Mol Oncol; 2018 Jun; 12(6):869-882. PubMed ID: 29624862
[TBL] [Abstract][Full Text] [Related]
18. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
19. p66Shc in Cardiovascular Pathology.
Haslem L; Hays JM; Hays FA
Cells; 2022 Jun; 11(11):. PubMed ID: 35681549
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
